Article info

Download PDFPDF
Original research
Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance: a nationwide multicentre study

Authors

  1. Correspondence to Professor Jeong-Hoon Lee, Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul 03080, South Korea; pindra{at}empal.com
View Full Text

Citation

Kim MA, Kim SU, Sinn DH, et al
Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance: a nationwide multicentre study

Publication history

  • Received October 6, 2019
  • Revised February 19, 2020
  • Accepted February 20, 2020
  • First published March 24, 2020.
Online issue publication 
November 06, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.